Physician profile
Aman Fatima
NPI 1336673565
$3,331.62
in general payments reported to CMS, 2019-2025
21 companies · $1,107 in 2025
The $1,107 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $41.50 · 2021: $1,687 · 2022: $175 · 2023: $135 · 2024: $187 · 2025: $1,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.19 |
| Travel and Lodging | $488.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,029.24 | 2021-2025 | |
| Fortis Surgical, LLC | $332.70 | 2021-2025 | |
| Stryker Corporation | $223.66 | 2024-2025 | Augment Injectable, Prostep Mica, Fuseforce |
| Organogenesis INC. | $100.09 | 2024-2025 | Apligraf, Cygnus Dual |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $99.54 | 2022 | |
| Biowound Solutions, INC. | $76.76 | 2025 | Bio-Connekt |
| Smith+Nephew, INC. | $72.24 | 2021-2025 | Iodosorb Ointment 40g USA, Collagenase Santyl |
| Integra Lifesciences Corporation | $56.22 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Averitas Pharma INC. | $41.08 | 2023 | Qutenza |
| Acumed LLC | $40.25 | 2024 | Acumed, Osteomed |
| Grt US Holding, INC. | $35.17 | 2022 | |
| Abbott Laboratories | $31.50 | 2025 | Eterna |
| Ossio INC | $30.10 | 2023 | |
| Reapplix INC. | $27.69 | 2025 | 3c Patch Kit - Box |
| Kowa Pharmaceuticals America, INC. | $26.56 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $25.38 | 2020 | |
| Depuy Synthes Sales INC. | $21.14 | 2023 | Va-Lcp |
| Allergan, INC. | $16.12 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.95 | 2024 | Nuzyra |
| Ibsa Pharma INC. | $15.79 | 2023 | Tirosint, Licart |
| Medtronic, INC. | $14.44 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Fatima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.